IRCCS Ospedale Policlinico San Martino
IRCCS Ospedale Policlinico San Martino
Genova, Genova, Italy4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers | Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Site, Nose Neoplasms, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, head and neck cancer, malignant tumor of nasopharynx, middle ear carcinoma, mouth disorder, nasal cavity and paranasal sinus carcinoma, nasal disorder, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease, paranasal sinus disorder, paranasal sinus neoplasm, respiratory system disorder, respiratory tract neoplasm, salivary gland cancer, salivary gland disorder | Recruiting | Not stated | 2026-04-03 | NCT05483374 | |
| stereOtactic Body RadIothErapy for exTracranial oligomeTastAtic Breast Cancer: Multi Institutional Retrospective Database | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not stated | 2026-02-11 | NCT07397585 | |
| Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, Neoplasms by Histologic Type, acute myeloid leukemia, anemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myelodysplastic syndrome with excess blasts, myelodysplastic syndrome with single lineage dysplasia, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2025-03-24 | NCT06892223 | |
| NEOadjuvant Abemaciclib and GIredestrant TriaL in Patients with ER-positive, HER2-negative Early Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2025-02-18 | NCT06259929 |